Matinas BioPharma Holdings (MTNB) Return on Capital Employed Growth (3y) (2017 - 2026)
Matinas BioPharma Holdings (MTNB) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -494.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | -10,078.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,078.00 |
| Dec 31, 2025 | -4,090.00 |
| Sep 30, 2025 | -9,528.00 |
| Jun 30, 2025 | -11,133.00 |
| Mar 31, 2025 | -15,701.00 |
| Dec 31, 2024 | -13,501.00 |
| Sep 30, 2024 | -7,010.00 |
| Jun 30, 2024 | -8,687.00 |
| Mar 31, 2024 | -8,342.00 |
| Dec 31, 2023 | -6,081.00 |
| Sep 30, 2023 | -4,980.00 |
| Jun 30, 2023 | -3,931.00 |
| Mar 31, 2023 | -2,115.00 |
| Dec 31, 2022 | -1,070.00 |
| Sep 30, 2022 | -1,775.00 |
| Jun 30, 2022 | -2,163.00 |
| Mar 31, 2022 | -213.00 |
| Dec 31, 2021 | 6,080.00 |
| Sep 30, 2021 | 8,196.00 |
| Jun 30, 2021 | 9,239.00 |